Paper
Differential interactions of the catalytic subunits of adenylyl cyclase with forskolin analogs.
Published Jul 1, 2009 · Cibele S. Pinto, M. Hübner, A. Gille
Biochemical pharmacology
Q1 SJR score
22
Citations
1
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Forskolin activation involves a two-step mechanism, with diterpenes promoting C1/C2 assembly and hydrogen bonding forming a conformational switch that activates adenylyl cyclase.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Characterization of Mouse Heart Adenylyl Cyclase
AC5 is an important adenylyl cyclase isoform in the heart, with MANT-ITP being a promising starting point for designing AC5-selective inhibitors for chronic heart failure.
2009·44citations·Martin Göttle et al.·Journal of Pharmacology and Experimental Therapeutics
Journal of Pharmacology and Experimental Therapeutics
Activation and Inhibition of Adenylyl Cyclase Isoforms by Forskolin Analogs
Forskolin and its analogs show diverse activation and inhibition profiles, demonstrating the feasibility of designing isoform-selective activators for adenylyl cyclase.
2008·78citations·Cibele S. Pinto et al.·Journal of Pharmacology and Experimental Therapeutics
Journal of Pharmacology and Experimental Therapeutics
Determining the Potency and Molecular Mechanism of Action of Insurmountable Antagonists
Insurmountable antagonist potency can be estimated using pA2 measurements, and special experiments are needed to differentiate between orthosteric and allosteric mechanisms.
2006·178citations·T. Kenakin et al.·Journal of Pharmacology and Experimental Therapeutics
Journal of Pharmacology and Experimental Therapeutics
Broad Specificity of Mammalian Adenylyl Cyclase for Interaction with 2′,3′-Substituted Purine- and Pyrimidine Nucleotide Inhibitors
The binding site of mammalian adenylyl cyclase exhibits broad specificity, accommodating various bases and fluorescent groups at the 2′,3′-O-ribosyl position, facilitating the rational design of potent, isoform-selective inhibitors.
2006·59citations·T. Mou et al.·Molecular Pharmacology
Molecular Pharmacology
Structural Basis for the Inhibition of Mammalian Membrane Adenylyl Cyclase by 2 ′(3′)-O-(N-Methylanthraniloyl)-guanosine 5 ′-Triphosphate*
MANT-GTP inhibits mammalian adenylyl cyclase with high potency, binding more tightly to the enzyme's most active form and influencing isoform selectivity.
2005·78citations·T. Mou et al.·Journal of Biological Chemistry
Journal of Biological Chemistry
Citations
Natural products as modulators of the cyclic-AMP pathway: evaluation and synthesis of lead compounds.
Natural products like alotaketals and ansellones show promise as modulators of the cyclic-AMP pathway, offering potential for drug discovery in CNS disorders, inflammation, and cardiac syndromes.
2018·18citations·S. Sengupta et al.·Organic & biomolecular chemistry
Organic & biomolecular chemistry
International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases
Mammalian adenylyl cyclases play diverse roles in cell functions, but our understanding of their pathophysiology and development of clinically useful drugs targeting them is in its infancy.
2017·166citations·C. Dessauer et al.·Pharmacological Reviews
Pharmacological Reviews
Effects of forskolin and rolipram on serum leptin, resistin and adiponectin levels in diet induced obesity in Wistar rats
Rolipram prevents leptin and adiponectin alteration in diet-induced obesity in rats, but forskolin and rolipram show no effect on resistin levels.
2015·0citations·I. Mehmetoğlu et al.·Turkish Journal of Biochemistry
Turkish Journal of Biochemistry
Structure/Activity Relationships of (M)ANT- and TNP-Nucleotides for Inhibition of Rat Soluble Guanylyl Cyclase α1β1
TNP-GTP and 2′-MANT-3′-dATP are highly potent inhibitors of rat sGC11, potentially aiding in future crystallographic and fluorescence spectroscopy studies.
2014·8citations·S. Dove et al.·Molecular Pharmacology
Molecular Pharmacology
Isoform Selectivity of Adenylyl Cyclase Inhibitors: Characterization of Known and Novel Compounds
Compounds lacking the adenine chemical signature and targeting the ATP binding site can potentially develop adenylyl cyclase isoform-specific inhibitors, potentially benefiting heart disease and pain treatment.
2013·76citations·Cameron S. Brand et al.·The Journal of Pharmacology and Experimental Therapeutics
The Journal of Pharmacology and Experimental Therapeutics
Dynamics of Gαi1 interaction with type 5 adenylate cyclase reveal the molecular basis for high sensitivity of Gi-mediated inhibition of cAMP production.
AC5, by binding active Gi1, interferes with G-protein deactivation and reassembly, potentially sensitizing its own regulation.
2013·19citations·Markus Milde et al.·The Biochemical journal
The Biochemical journal
Allosteric Regulation of Nucleotidyl Cyclases: An Emerging Pharmacological Target
Targeting allosteric domains near the catalytic site of nucleotidyl cyclases offers new opportunities for pharmacological intervention, potentially achieving isoform specificity in diseases like cardiovascular diseases and aging.
2012·15citations·R. Seifert et al.·Science Signaling
Science Signaling
Interactions of Bordetella pertussis adenylyl cyclase toxin CyaA with calmodulin mutants and calmodulin antagonists: comparison with membranous adenylyl cyclase I.
The two-step activation mechanism of Bordetella pertussis adenylyl cyclase toxin CyaA by calmodulin offers potential for pharmacological intervention in treating whooping cough, with unique interactions between CyaA and calmodulin mutants.
2012·9citations·D. Schuler et al.·Biochemical pharmacology
Biochemical pharmacology
Inhibitors of membranous adenylyl cyclases.
Membranous adenylyl cyclases (mACs) play distinct roles, and developing isoform-selective inhibitors is crucial for understanding their function and potential therapeutic applications.
2012·105citations·R. Seifert et al.·Trends in pharmacological sciences
Trends in pharmacological sciences